RE
TFFP

RBC Europe’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

RBC Europe’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-29
Closed -$5.6K – 1196
2021
Q3 		$5.6K Buy
+29
New +$6.16K ﹤0.01% 1025

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return

RBC Europe's TFFP Position: Q4 2021 in Review

RBC Europe sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2021, closing a stake of 29 shares — an estimated $5.6K sold.

RBC Europe first reported a position in TFFP in Q3 2021 and held it in 1 quarter. The position peaked at $5.6K in Q3 2021. 51 funds tracked by Wall St. Rank hold TFFP as of Q4 2021.

  • RBC Europe reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 29 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $5.6K.
  • RBC Europe first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • RBC Europe's TFF Pharmaceuticals, Inc. Common Stock position peaked at $5.6K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.